Geron Competitors

GERN Stock  USD 1.38  0.03  2.13%   
Geron competes with Day One, Rezolute, Arvinas, Valneva SE, and Tyra Biosciences; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Geron competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Geron to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Geron Correlation with its peers.
To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.

Geron vs ArriVent BioPharma Correlation

Very weak diversification

The correlation between Geron and AVBP is 0.43 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Geron and AVBP in the same portfolio, assuming nothing else is changed.

Moving together with Geron Stock

  0.67ENGN enGene Holdings Common TrendingPairCorr

Moving against Geron Stock

  0.57FNMFO Federal National MortgagePairCorr
  0.55LEGN Legend Biotech CorpPairCorr
  0.49AAPG Ascentage Pharma Symbol ChangePairCorr
  0.48GALT Galectin TherapeuticsPairCorr
  0.45CCCC C4 TherapeuticsPairCorr
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.071.384.91
Details
Intrinsic
Valuation
LowRealHigh
0.061.144.67
Details
Naive
Forecast
LowNextHigh
0.031.434.96
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.251.341.42
Details

Geron Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Geron and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Geron and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Geron does not affect the price movement of the other competitor.

High positive correlations

LENZRZLT
AVBPSVRA
SVRAARVN
AVBPARVN
AVBPVIR
SVRATYRA
  

High negative correlations

TYRARZLT
LENZTYRA
REPLVALN
REPLDAWN
SVRARZLT
LENZSVRA

Risk-Adjusted Indicators

There is a big difference between Geron Stock performing well and Geron Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Geron's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
DAWN  4.53  0.95  0.22  2.29  3.62 
 13.81 
 39.62 
RZLT  7.16  0.77  0.03 (0.13) 15.64 
 18.05 
 99.29 
ARVN  3.05  0.54  0.14  5.28  3.16 
 5.91 
 28.90 
VALN  2.18  0.05  0.02  0.11  2.21 
 4.83 
 14.16 
TYRA  2.75  1.33  0.47 (2.54) 1.64 
 6.05 
 34.11 
VIR  3.51  0.30  0.08  0.23  3.86 
 8.08 
 20.46 
SVRA  3.10  0.51  0.17  0.47  2.92 
 8.25 
 24.50 
REPL  2.77 (0.30) 0.00 (0.37) 0.00 
 5.56 
 20.44 
LENZ  4.15 (0.48) 0.00  11.17  0.00 
 8.05 
 40.02 
AVBP  3.16  0.32  0.08  0.70  3.25 
 6.71 
 16.37 

Geron Competitive Analysis

The better you understand Geron competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Geron's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Geron's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
GERN DAWN RZLT ARVN VALN TYRA VIR SVRA REPL LENZ
 2.13 
 1.38 
Geron
 3.16 
 11.95 
Day
 7.65 
 3.52 
Rezolute
 2.55 
 12.89 
Arvinas
 5.15 
 9.77 
Valneva
 1.75 
 30.37 
Tyra
 2.16 
 7.56 
Vir
 6.81 
 6.02 
Savara
 2.41 
 7.71 
Replimune
 3.90 
 20.44 
LENZ
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Total Debt
Return On Equity
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Earnings To Growth
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Geron Competition Performance Charts

Five steps to successful analysis of Geron Competition

Geron's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Geron in relation to its competition. Geron's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Geron in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Geron's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Geron, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Geron position

In addition to having Geron in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Military Industrial Thematic Idea Now

Military Industrial
Military Industrial Theme
A collection of large United States defense contractors including companies involved in production or distribution of aircraft, ships, vehicles, weaponry, and electronic systems in cooperation with the government. The Military Industrial theme has 33 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Military Industrial Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Geron offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Geron's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Geron Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Geron Stock:
Check out Geron Correlation with its peers.
To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Geron. If investors know Geron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Geron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Geron is measured differently than its book value, which is the value of Geron that is recorded on the company's balance sheet. Investors also form their own opinion of Geron's value that differs from its market value or its book value, called intrinsic value, which is Geron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Geron's market value can be influenced by many factors that don't directly affect Geron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Geron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Geron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Geron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.